Recombinant Human Protein Kinase Inhibitor Alpha (PKIa), Unconjugated

Produktübersicht

• Artikelname: Recombinant Human Protein Kinase Inhibitor Alpha (PKIa), Unconjugated
• Artikelnummer: BIM-RPU43495
• Hersteller Artikelnummer: RPU43495
• Alternativnummer: BIM-RPU43495-50UG, BIM-RPU43495-100UG, BIM-RPU43495-1MG
• Hersteller: Biomatik Corporation
• Kategorie: Proteine/Peptide
• Applikation: Control, SDS-PAGE, WB
• Spezies Reaktivität: Human
• Konjugation: Unconjugated
• Alternative Synonym: PKI-A, PRKACN1, CAMP-Dependent Protein Kinase Inhibitor Alpha, cAMP-dependent protein kinase inhibitor, muscle/brain isoform

Produktbeschreibung

Recombinant Human Protein Kinase Inhibitor Alpha (PKIa) is a purified Prokaryotic Protein. Purity: >97% by SDS-PAGE. Host: E. coli. Endotoxin Level: <1.0EU per 1ug, by the LAL method. Species: Human (Homo sapiens). Target Name: Protein Kinase Inhibitor A

Produkteigenschaften

• Molekulargewicht: 14kDa
• Tag: N-terminal His Tag
• NCBI: 5569
• Puffer: PBS, pH7.4, containing 0.01% SKL, 5% Trehalose.
• Expression System: Prokaryotic Expression
• Reinheit: >97% by SDS-PAGE
• Formulierung: Freeze-Dried Powder
• Target-Kategorie: Protein Kinase Inhibitor Alpha (PKIa)